| Novel technique (Anatolian neobladder) (n = 36) | Standard technique (Studer neobladder) (n = 16) | p |
---|---|---|---|
Age, years, mean ± SD | 54.7 ± 11.6 | 58.0 ± 4.9 | 0.16 |
Sex |  |  | > 0.999 |
 -Male | 34 (94.4%) | 15 (93.7%) |  |
 -Female | 2 (5.6%) | 1 (6.3%) |  |
ASA | 2 (1–3) | 2 (1–3) | 0.77 |
Chemotherapy | |||
 -Neo-adjuvant | 9 (25%) | 4 (25%) | > 0.99 |
 -Adjuvant | 2 (5.5%) | 1 (6.2%) | > 0.99 |